ClinicalTrials.Veeva

Menu

Invest-CTO PCI Trial

H

Haukeland University Hospital

Status

Active, not recruiting

Conditions

Quality of Life
Angina Pectoris
Chronic Total Occlusion of Coronary Artery
PROM

Treatments

Procedure: Chronic total occlusion(CTO) percutaneous coronary intervention (PCI)

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Following unsuccessful CTO crossing a CTO modification procedure is sometimes performed. CTO PCI registries where plaque modification has been performed in some patients, report this to be safe, and associated with higher success rates at subsequent attempts.

It has never been investigated whether a planned investment procedure, with an intention that both the initial and staged completion PCI are of shorter duration, could improve safety and efficacy.

The investigators hypothesize that

  1. A planned investment procedure in the treatment of CTOs will be associated with improved patient safety
  2. A planned investment procedure will be associated with improved cumulative procedure success rates
  3. A planned two stage procedure will be associated with improved patient experience

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Ability to provide written informed consent
  • Comply with the procedural and study follow-up schedule
  • Planned CTO PCI in accordance with the European and American appropriateness criteria.
  • CTO defined as high-risk

Exclusion criteria

  • Non-high risk CTO
  • Occlusion within a stent
  • Flush aorto-ostial occlusion of RCA and Left Main (LMS)
  • Limited arterial access precluding repeat procedure
  • Baseline non invasive testing showing non-viable target vessel territory
  • Contra-indication to dual antiplatelet therapy
  • Pregnancy
  • Prior radiation skin injury
  • Lack of informed consent

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

200 participants in 1 patient group

Invest CTO PCI
Experimental group
Description:
A pre-planned two staged procedure in high-risk CTO PCI
Treatment:
Procedure: Chronic total occlusion(CTO) percutaneous coronary intervention (PCI)

Trial contacts and locations

5

Loading...

Central trial contact

Anja Øksnes, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems